Business Description
Arich Enterprise Co Ltd
ISIN : TW0004173000
Total Employee Number:
180Compare
Compare
Traded in other countries / regions
4173.Taiwan IPO Date
2013-10-31Description
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioners, and key accounts which include chain stores and hypermarkets, drug stores, and wholesalers. The product portfolio includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.25 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | 3.44 | |||||
Interest Coverage | 13.75 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1 | |||||
Beneish M-Score | -0.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15 | |||||
3-Year EBITDA Growth Rate | 13.6 | |||||
3-Year EPS without NRI Growth Rate | 11.3 | |||||
3-Year Book Growth Rate | 2.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.47 | |||||
9-Day RSI | 44.5 | |||||
14-Day RSI | 44.44 | |||||
3-1 Month Momentum % | -10.49 | |||||
6-1 Month Momentum % | -16.59 | |||||
12-1 Month Momentum % | -21.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.44 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 29.34 | |||||
Days Sales Outstanding | 48.44 | |||||
Days Payable | 60.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.79 | |||||
Dividend Payout Ratio | 1.01 | |||||
3-Year Dividend Growth Rate | 33.4 | |||||
Forward Dividend Yield % | 5.79 | |||||
5-Year Yield-on-Cost % | 12.1 | |||||
Shareholder Yield % | -7.56 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 20.08 | |||||
Operating Margin % | 6.69 | |||||
Net Margin % | 5.61 | |||||
EBITDA Margin % | 11.91 | |||||
FCF Margin % | -123.53 | |||||
OCF Margin % | -123.05 | |||||
ROE % | 4.48 | |||||
ROA % | 1.5 | |||||
ROIC % | 5.79 | |||||
3-Year ROIIC % | 4.24 | |||||
ROC (Joel Greenblatt) % | 78.36 | |||||
ROCE % | 5.66 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.51 | |||||
PE Ratio without NRI | 15.23 | |||||
Shiller PE Ratio | 17.79 | |||||
PEG Ratio | 1.46 | |||||
PS Ratio | 0.87 | |||||
PB Ratio | 0.67 | |||||
Price-to-Tangible-Book | 0.67 | |||||
EV-to-EBIT | 10.14 | |||||
EV-to-EBITDA | 6.42 | |||||
EV-to-Revenue | 0.77 | |||||
EV-to-FCF | -0.62 | |||||
Price-to-GF-Value | 0.59 | |||||
Price-to-Projected-FCF | 0.36 | |||||
Price-to-Median-PS-Value | 0.82 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.02 | |||||
Price-to-Graham-Number | 0.67 | |||||
| Price-to-Net-Current-Asset-Value | 1.06 | |||||
Earnings Yield (Greenblatt) % | 9.86 | |||||
FCF Yield % | -142.36 | |||||
Forward Rate of Return (Yacktman) % | 24.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arich Enterprise Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,546.999 | ||
| EPS (TTM) (NT$) | 1.16 | ||
| Beta | -0.0638 | ||
| 3-Year Sharpe Ratio | -0.7 | ||
| 3-Year Sortino Ratio | -0.87 | ||
| Volatility % | 17.29 | ||
| 14-Day RSI | 44.44 | ||
| 14-Day ATR (NT$) | 0.187461 | ||
| 20-Day SMA (NT$) | 18.055 | ||
| 12-1 Month Momentum % | -21.41 | ||
| 52-Week Range (NT$) | 17.75 - 25.75 | ||
| Shares Outstanding (Mil) | 74.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arich Enterprise Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arich Enterprise Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.040000 Cash Dividend | 2026-04-16 | 20.50 (-0.73%) | ||
| TWD 1.188202 Cash Dividend | 2025-04-17 | 23.10 (-1.49%) |
Show
Entries
Arich Enterprise Co Ltd Frequently Asked Questions
What is Arich Enterprise Co Ltd(ROCO:4173)'s stock price today?
The current price of ROCO:4173 is NT$18.00. The 52 week high of ROCO:4173 is NT$25.75 and 52 week low is NT$17.75.
When is next earnings date of Arich Enterprise Co Ltd(ROCO:4173)?
The next earnings date of Arich Enterprise Co Ltd(ROCO:4173) is .
Does Arich Enterprise Co Ltd(ROCO:4173) pay dividends? If so, how much?
The Dividend Yield %  of Arich Enterprise Co Ltd(ROCO:4173) is 5.79% (As of Today), Highest Dividend Payout Ratio of Arich Enterprise Co Ltd(ROCO:4173) was 4.44. The lowest was 0.27. And the median was 0.71. The  Forward Dividend Yield % of Arich Enterprise Co Ltd(ROCO:4173) is 5.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Arich Enterprise Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers